Evidence map›Paper›PMID 35034629›Full record

ArticleBMC gastroenterology2022

Serum ferritin levels are associated with advanced liver fibrosis in treatment-naive autoimmune hepatitis.

Qingling Chen, Min Gao, Hang Yang, Ling Mei, Rui Zhong, Ping Han, Peiyan Liu, Lili Zhao, Jing Wang, Jia Li

Open access · goldAbstract read
In one paragraph

Article in BMC gastroenterology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Iron as a therapeutic target in chronic liver disease.World journal of gastroenterology · 2023
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Qingling Chen *Department of Hepatology, Second People's Clinical College of Tianjin Medical University, Tianjin, China.
Min Gao *Department of Hepatology, Tianjin Second People's Hospital, No. 7, Sudi South Road, Nankai District, Tianjin, 300192, China.
Hang YangDepartment of Hepatology, Second People's Clinical College of Tianjin Medical University, Tianjin, China.
Ling MeiDepartment of Hepatology, Second People's Clinical College of Tianjin Medical University, Tianjin, China.
Rui ZhongDepartment of Neurology, The First Hospital of Jilin University, Changchun, Jilin, China.
Ping HanDepartment of Hepatology, Tianjin Second People's Hospital, No. 7, Sudi South Road, Nankai District, Tianjin, 300192, China.
Peiyan LiuDepartment of Hepatology, Second People's Clinical College of Tianjin Medical University, Tianjin, China.
Lili ZhaoDepartment of Hepatology, Tianjin Second People's Hospital, No. 7, Sudi South Road, Nankai District, Tianjin, 300192, China.
Jing WangDepartment of Hepatology, Tianjin Second People's Hospital, No. 7, Sudi South Road, Nankai District, Tianjin, 300192, China.
Jia LiDepartment of Hepatology, Tianjin Second People's Hospital, No. 7, Sudi South Road, Nankai District, Tianjin, 300192, China. 18622663700@163.com.
Tianjin Medical University · CNFirst Hospital of Jilin University · CNSecond Hospital of Tianjin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimThe association between iron-metabolism-related variables and liver fibrosis in chronic hepatitis C and nonalcoholic fatty liver disease is now well known. However, the relationship has not been extensively studied in autoimmune hepatitis (AIH). We aimed to investigate the association between variables associated with iron metabolism and advanced liver fibrosis among untreated patients with AIH.

methodsNinety-seven untreated AIH patients were enrolled in this cross-sectional study. All participants underwent iron metabolism index detection and liver biopsy. Multiple logistic regression analysis was used to explore the association of iron-metabolism-related variables with advanced liver fibrosis.

resultsAmong the 97 AIH patients, 38 (39.2%) had advanced liver fibrosis, and 59 (60.8%) did not. In multivariate logistic regression analysis, immunoglobulin G (odds ratio [OR], 1.123; 95% confidence interval [CI] 1.023-1.232, P = 0.014), platelet count (OR 0.988; 95% CI 0.979-0.997, P = 0.013), prothrombin time (OR 1.758; 95% CI 1.143-2.704, P = 0.010) and ferritin (OR 1.002; 95% CI 1.001-1.004, P = 0.012) were independent risk factors for predicting advanced liver fibrosis in AIH patients.

conclusionHigher serum ferritin was independently associated with advanced liver fibrosis among patients with treatment-naive AIH.

Indexed as

Hepatitis, AutoimmuneHepatitis C, ChronicCross-Sectional StudiesFerritinsHumansLiverLiver CirrhosisFerritinsAutoimmune hepatitisFerritinIron metabolism disordersLiver fibrosis

Identifiers

PMID35034629
PMCPMC8762965
OpenAlexW4205873542

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.